---
slug: phase-1-m2-task-6-permissiongraph-case-aware-coverage
created: 2026-05-08T11:12:08+08:00
last_updated: 2026-05-08T11:25:25+08:00
status: approved
total_rounds: 1
max_iterations: 5
reviewer_model: opus
review_scope: branch 2296289..HEAD
---

# Claude Review Loop - Phase 1 M2 Task 6 PermissionGraph Case-Aware Coverage

<goal_contract>
Task: Review Phase 1 M2 Task 6, which upgrades PermissionGraph / EffectivePermissions
from raw Set subtraction to case-aware declared-covers-effective permission coverage.
This matters because Phase 1 tools must be able to declare broader file and MCP
permissions without creating execution-gate or audit false positives, while still
failing closed for sensitive paths and unsupported shell semantics.

In-scope:
- SliceAIKit/Sources/Orchestration/Permissions/EffectivePermissions.swift
- SliceAIKit/Sources/Orchestration/Permissions/PermissionGraph.swift
- SliceAIKit/Sources/Orchestration/Events/InvocationReport.swift
- SliceAIKit/Sources/Capabilities/SecurityKit/PathSandbox.swift
- SliceAIKit/Tests/OrchestrationTests/PermissionGraphTests.swift
- SliceAIKit/Tests/OrchestrationTests/InvocationReportTests.swift
- README.md
- docs/Module/Capabilities.md
- docs/Module/Orchestration.md
- docs/Task_history.md
- docs/Task-detail/2026-05-07-phase-1-m2-task-6-permissiongraph-case-aware-coverage.md
- docs/v2-refactor-master-todolist.md

Out-of-scope:
- M1 Task 1-5 MCP configuration, stdio client, and Settings UI behavior before base commit 2296289.
- M2 Task 7 ContextProviders and later persistent/session grant UI work.
- Adding real shell execution, Streamable HTTP, legacy SSE, or new MCP transports.
- Broad permission architecture redesign beyond Task 6 coverage semantics.

Definition of Done:
1. Claude returns the explicit approve signal (`verdict: "approve"` and `findings: []`)
   OR all remaining findings are low and rejected/deferred with stable reasons.
2. Relevant tests pass.
3. No accepted critical/high finding remains unfixed.

Max iterations: 5, upper bound only; exit early on approve.
</goal_contract>

<reference_documents>
- Current project status: README.md
- Task implementation notes: docs/Task-detail/2026-05-07-phase-1-m2-task-6-permissiongraph-case-aware-coverage.md
- Phase 1 implementation plan Task 6: /Users/majiajun/workspace/SliceAI/docs/superpowers/plans/2026-05-06-phase-1-mcp-context.md
- Module notes: docs/Module/Orchestration.md
- Module notes: docs/Module/Capabilities.md
</reference_documents>

<prior_round_decisions>
None yet.
</prior_round_decisions>

<review_constraints>
- Material findings only.
- Keep the review inside in-scope. Out-of-scope items must be `[ADVISORY]`.
- Challenge rejected findings only with new evidence.
- Prefer root-cause findings over symptom lists.
- Flag KISS violations only when they create concrete risk or scope creep.
- Reject low-value filler, but list all same-severity material findings before returning.
- Do not stop after the first critical/high issue when another material issue of that same severity is in scope.
- If no material findings remain, emit the approve signal: `verdict: "approve"` with `findings: []`.
</review_constraints>

<round_meta>
Round: 1
Loop max iterations: 5, upper bound only
Cumulative files changed in loop so far: 0
</round_meta>

## Goal Contract

**Task.** Review Phase 1 M2 Task 6 case-aware permission coverage for correctness,
security boundary consistency, audit consistency, and test coverage.

**Reference Documents.**
- Current project status: `README.md`
- Task implementation notes: `docs/Task-detail/2026-05-07-phase-1-m2-task-6-permissiongraph-case-aware-coverage.md`
- Phase 1 implementation plan Task 6: `/Users/majiajun/workspace/SliceAI/docs/superpowers/plans/2026-05-06-phase-1-mcp-context.md`
- Module notes: `docs/Module/Orchestration.md`
- Module notes: `docs/Module/Capabilities.md`

**In-scope.**
- `SliceAIKit/Sources/Orchestration/Permissions/EffectivePermissions.swift`
- `SliceAIKit/Sources/Orchestration/Permissions/PermissionGraph.swift`
- `SliceAIKit/Sources/Orchestration/Events/InvocationReport.swift`
- `SliceAIKit/Sources/Capabilities/SecurityKit/PathSandbox.swift`
- `SliceAIKit/Tests/OrchestrationTests/PermissionGraphTests.swift`
- `SliceAIKit/Tests/OrchestrationTests/InvocationReportTests.swift`
- Task 6 docs listed above.

**Out-of-scope.**
- M1 Task 1-5 changes before base commit `2296289`.
- M2 Task 7 and later tasks.
- Real shell execution, Streamable HTTP, legacy SSE, or new MCP transport implementation.
- Broad redesign beyond Task 6 coverage semantics.

**Definition of Done.**
1. Claude returns the explicit approve signal: `verdict: "approve"` and `findings: []`,
   OR remaining findings are low and rejected/deferred with stable reasons.
2. Relevant tests pass.
3. No accepted critical/high finding remains unfixed.

**Max iterations.** 5 (upper bound; exit early on approve)

## Rounds

### Round 1 - 2026-05-08T11:25:25+08:00

- **Claude verdict.** approve
- **Severity counts.** 0 critical / 0 high / 0 medium / 0 low
- **Decision ledger.**

| # | Severity | Title | File:line | Decision | Reason / fix plan |
|---|---|---|---|---|---|
| - | - | No findings | - | - | Claude returned `verdict: "approve"` with `findings: []`. |

- **Root-cause groups.** None.
- **Fix applied.** None; review found no material issues.
- **Tests.** No new tests were required during the review loop. Existing Task 6 verification already passed: `swift test --filter OrchestrationTests.InvocationReportTests`, `swift test --filter OrchestrationTests.PermissionGraphTests`, `swift test --filter OrchestrationTests.ExecutionEngineTests`, `swift test --filter CapabilitiesTests.PathSandboxTests`, full `swift test`, and `git diff --check 2296289..HEAD`.
- **Files touched.** `docs/Task-detail/claude-loop-phase-1-m2-task-6-permissiongraph-case-aware-coverage.md`
- **Drift.** in-scope-only.
- **Status.** exit-approve.

## Final Summary

**Termination reason.** Claude returned explicit approve in round 1.
**Total rounds.** 1.
**Final verdict.** approve.
**Net findings.**
- Accepted and fixed: 0
- Rejected: 0
- Deferred: 0
- Partial: 0
**Deferred follow-ups.**
- None.
